Tag: $VMW

Positive sentiments for Bluebird Bio and VMWare

BLUE – Bluebird Bio Inc is focused on developing and commercializing drugs based on gene therapy to treat patients with genetic diseases and cancer.

BLUE – Bluebird Bio Inc

Fundamentals Previously closed at 47.72
Day’s high 51.46
Day’s low 47.61
P/E ratio NA
EPS -2.44

 

Analysts opinion Bluebird Bio announced that its ongoing phase 2 study evaluating the product candidate “Lenti-D” for the treatment of cerebral adrenoleukodystrophy (CALD) will be presented today at the American Academy of Neurology (AAN) Annual Meeting. The news for the investigational drug Lenti- D seems to be positive, with all patients remaining free of MFDs, and consistent safety-profile. The revenues for the stock is expected to be reported on May 4th, and analysts estimate EPS at $-1.19. Technically, bluebird has formed a double-bottom chart pattern, and is expected to be bullish.
Sentiments Also, Deutsche Bank AG and Bank of America Corp DE have boosted their stakes in BLUE and investor sentiment seems to be bullish.
Social Media Pulse The stock has 100% higher chatter than usual.

 

Continue Reading…